Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 530 participants.
Also called NCT05462730
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 530 participants
- Sponsor
- Thomas Engstrom
- Registry
-
NCT05462730
-
- Other papers using this trial's data
- Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial Infarction: The PULSE-MI Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT05462730. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-14 (actual); primary completion 2024-01-30 (actual). Results posted on 2026-03-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
- Acronym
- PULSE-MI
- Condition
- ST Elevation Myocardial Infarction
- Condition
- Inflammatory Response
- Condition
- Myocardial Reperfusion Injury
- Condition
- Myocardial Injury
- Intervention (Drug)
- Methylprednisolone
- Intervention (Drug)
- Isotonic saline
- Lead sponsor
- Thomas Engstrom
Record details
- Record id
cardio:ct-nct05462730- Content hash
a8d4b7d22354dc762877cb230df19180f01d983e515b8aa0695123621c1d406c